Abstract
Nodal status is a sensitive prognostic indicator in breast cancer. Axillary metastases may be an indication for neoadjuvant systemic therapy. The aims of this study were to compare pathologic response rates to neoadjuvant chemotherapy (NAC) in the breast and axilla across different molecular subtypes of breast cancer and to compare the predictive value of axillary assessment before and after chemotherapy in determining final nodal status in this cohort of patients.
| Original language | English (Ireland) |
|---|---|
| Pages (from-to) | 20-25 |
| Number of pages | 6 |
| Journal | Cancer |
| Volume | 14 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Oct 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Axilla
- Breast cancer
- HER2
- Neoadjuvant chemotherapy
- Pathologic response
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- McVeigh TP, Al-Azawi D, Kearney DE, Malone C, Sweeney KJ, Barry K, McLaughlin R, Keane M, Kerin MJ
- McVeigh, TP,Al-Azawi, D,Kearney, DE,Malone, C,Sweeney, KJ,Barry, K,McLaughlin, R,Keane, M,Kerin, MJ
Fingerprint
Dive into the research topics of 'Assessing the Impact of Neoadjuvant Chemotherapy on the Management of the Breast and Axilla in Breast Cancer.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver